NRG Therapeutics Selects Domainex to be its Integrated Drug Discovery Partner for its Biomedical Catalyst Funded Parkinson’s Disease Project

MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease

MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management through predictive analytics, today announce their partnership to conduct an observational clinical study on patients with chronic metabolic disease and increased risk of complications such as chronic kidney disease. The partnership will provide access to data from patient populations in Asia that have historically been underrepresented in chronic metabolic disease studies.

Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies

Saama Technologies Announces Appointment of New CEO Vivek Sharma

#1 AI clinical analytics platform company Saama Technologies welcomes global life sciences industry expert Vivek Sharma as new CEO

Kyruus Announces Paul Merrild as Company’s First President

Leadership Team Expansion Follows Year of Accelerated Growth

PHASTAR Names Chris Schoonmaker as Chief Operations Officer

PHASTAR Names Chris Schoonmaker as Chief Operations Officer  London, UK and Durham, NC - June 29, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Chris Schoonmaker has joined the company as Chief Operations Officer. Chris will direct PHASTAR’s operational strategy with a key focus on ensuring quality deliverables and providing a positive customer experience.

Alzheimer’s Disease Diagnostic Market – Global Industry Size, Trends and COVID-19 Impact Analysis (2022 to 2028)

Sharp Adds New Talent in Global Operations and Finance to Senior Leadership Team

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

Citeline and Norstella Unite to create a new organization that will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient

BOC Sciences Demonstrates Comprehensive Strength with LYTAC Technology

BOC Sciences demonstrates its comprehensive strength with innovative LYTAC degradation technology solutions developed in the field of targeted protein degradation.

One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases

Creative Biogene offers one-stop mitochondria-focused testing services for the evaluation of a variety of cardiac diseases associated with mitochondrial dysfunction.

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

MMS Holdings, a contract research organization, announced today that Lindsay Goldberg, a private equity firm, has completed an investment in the company. The partnership will help MMS expand its data-focused clinical research services.

Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Lipidomics Introduces Glycerophospholipids Analysis Service

Creative Proteomics Metabolomics Expands Service Offering with the Launch of Food Metabolomics Service

‘My Healthy Maryland’ Study Launches on Vibrent Health Platform, Using Next-Generation Digital Research Tools to Create Biggest and Most Diverse Health Database in State

University of Maryland Medicine Precision Health Study Utilizes Vibrent Health’s Accessible and Scalable Online Platform with a Goal to Enroll 250,000 Diverse Maryland Residents to Learn How Genes and Other Factors Affect Health

Cotiviti to Share Expertise on the Role of Quality in Improving Healthcare Outcomes at RISE Qualipalooza Conference

Senior Vice President Rachael Jones to co-chair RISE event focused on improving quality of care and member experience

ObvioHealth announces a groundbreaking partnership with Dedalus Group to unite real world & clinical trial data

ObvioHealth, a global virtual research organization (VRO), is bringing clinical trial data fully into the continuum of care through a new strategic partnership with Dedalus Group, the leading healthcare and diagnostic software solutions provider in Europe.

Novel PTSD Treatment Advances Toward Regulatory Evaluation with New Collaboration Between MAPS PBC and MMS Holdings

On PTSD Awareness Day, MAPS PBC announces plans to develop the New Drug Application for MDMA-assisted therapy in collaboration with MMS Holdings The second Phase 3 trial of the Breakthrough-Designated Therapy for PTSD will be completed in late 2022, with a targeted NDA submission in 2023 supported by MMS Holdings MMS Holdings, which specializes in supporting first-in-class NDAs, was selected for extensive experience in neuroscience

MicrobioSeq Boosts Microbial Diversity Research with Eukaryotic 18S rRNA Sequencing